Physician profile
Clinton Young
NPI 1538119094
$20,454.38
in general payments reported to CMS, 2019-2025
45 companies · $3,814 in 2025
The $3,814 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,763 · 2020: $1,291 · 2021: $2,123 · 2022: $3,089 · 2023: $3,537 · 2024: $3,837 · 2025: $3,814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,016.96 |
| Education | $170.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,921.82 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $2,696.40 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,127.22 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| United Therapeutics Corporation | $1,769.61 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Genzyme Corporation | $1,063.98 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $943.26 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $889.07 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $855.69 | 2019-2025 | Prolastin-C Liquid |
| Insmed, INC. | $699.76 | 2019-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $626.93 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Merck Sharp & Dohme LLC | $563.54 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Novartis Pharmaceuticals Corporation | $501.89 | 2019-2025 | |
| Amgen INC. | $496.05 | 2021-2025 | Tezspire |
| Verona Pharma, INC. | $431.49 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $407.28 | 2020-2025 | Glassia |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $388.24 | 2021-2024 | Teflaro, Avycaz |
| Viatris Specialty LLC | $348.51 | 2025 | Yupelri |
| Electromed, INC. | $287.27 | 2019-2025 | Smartvest |
| Genentech USA, INC. | $273.77 | 2019-2024 | Xolair |
| Mallinckrodt Hospital Products INC. | $244.44 | 2020-2024 | Acthar |
| Teva Pharmaceuticals USA, INC. | $231.99 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $223.26 | 2019-2020 | |
| Shionogi INC | $186.78 | 2022-2024 | Fetroja |
| Harmony Biosciences LLC | $142.01 | 2021-2025 | Wakix |
| Baxter Healthcare | $127.05 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Janssen Pharmaceuticals, INC | $103.87 | 2020-2021 | |
| La Jolla Pharmaceutical Company | $101.09 | 2019-2020 | |
| Inogen, INC. | $99.41 | 2022-2025 | |
| Circassia INC. | $95.05 | 2019-2020 | |
| Philips North America LLC | $91.00 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $68.39 | 2025 | |
| Alexion Pharmaceuticals, INC. | $61.61 | 2019-2020 | |
| Breas Medical, INC. | $61.47 | 2024 | Vivo 45 Ls |
| Csl Behring | $49.65 | 2021 | |
| Allergan, INC. | $45.28 | 2019-2020 | |
| Axsome Therapeutics, INC. | $38.60 | 2025 | Sunosi |
| Advanced Respiratory, INC | $36.77 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $34.93 | 2022-2025 | Purified Cortrophin Gel |
| Pfizer INC. | $32.39 | 2024 | |
| Vifor Pharma, INC. | $18.66 | 2025 | Zemaira |
| Avadel Cns Pharmaceuticals, LLC | $18.32 | 2024 | Lumryz |
| Ambu INC. | $13.24 | 2023 | |
| Inspire Medical Systems, INC. | $13.24 | 2023 | Inspire |
| Paratek Pharmaceuticals, INC. | $12.42 | 2022 | |
| Quidel Corporation | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.